Feature Channels:

Men's Health

Add to Favorites Subscribe Share
fbshare-Men's Health

Showing results

110 of 683
Embargo will expire:
22-May-2019 5:00 PM EDT
Released to reporters:
21-May-2019 1:05 PM EDT


A reporter's PressPass is required to access this story until the embargo expires on 22-May-2019 5:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    21-May-2019 11:00 AM EDT

Article ID: 712981

New Technique Promises Improved Metastatic Prostate Cancer Detection

American Institute of Physics (AIP)

Results reported in Biomicrofluidics promise a new way to detect prostate cancer through a simple device, which forces cell samples through channels less than 10 microns wide. When prostate cancer cells are forced through, the metastatic cells exhibit “blebbing,” and the experiments show that highly metastatic prostate cancer cells are more likely to exhibit blebbing than normal cells or even less-metastatic cells are. The new device could be used in a clinical setting to inexpensively test large numbers of samples.

16-May-2019 9:35 AM EDT

Article ID: 713156

Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

Rensselaer Polytechnic Institute (RPI)

Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more precise and personalized. This work will be a critical component of a new interdisciplinary research project funded with $1.4 million from the National Institutes of Health (NIH) that seeks to improve radiation therapy for high-risk prostate cancer patients.

20-May-2019 10:05 AM EDT

Article ID: 713121

Prostate Cancer Research Examines Radiation Protocol for the Whole Pelvis

University of California, Los Angeles (UCLA), Health Sciences

In a new study published by European Urology, UCLA researchers and colleagues from ten other institutions examined the protocol for treating aggressive prostate cancer. With aggressive forms of this disease, it is often unclear if radiation therapy should be applied to the prostate alone or to the whole pelvis. The reason a low-dose of radiation may be applied to the whole pelvis is that pelvic lymph nodes may have microscopic cancer cells within them.

17-May-2019 4:20 PM EDT

Article ID: 712828

Johns Hopkins Researchers Find Widely “Inconsistent” Use of Antibodies in Lab Experiments

Johns Hopkins Medicine

Scientists at the Johns Hopkins Kimmel Center say they have affirmed widespread inconsistencies in the use of a common laboratory procedure called immunohistochemical staining, and say the variations are making many laboratory experiments unreliable.

15-May-2019 8:00 AM EDT

Article ID: 712771

New Insights into Treatment Targets for Men with Advanced Prostate Cancers

Huntsman Cancer Institute at the University of Utah

A study published recently in the Journal of Clinical Oncology Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, outlines findings from the largest-ever prospective genomic analysis of advanced prostate cancer tumors. Using comprehensive genomic profiling (CGP) to analyze thousands of tumor samples from men with advanced prostate cancers, the researchers identified that 57 percent of the samples evaluated had genomic characteristics that suggested the tumors were candidates for targeted therapies.

13-May-2019 12:05 PM EDT

Article ID: 712722

Older Fathers Put Health of Partners, Unborn Children at Risk, Rutgers Study Finds

Rutgers University-New Brunswick

Men who delay starting a family have a ticking “biological clock” — just like women — that may affect the health of their partners and children, according to Rutgers researchers.

11-May-2019 1:05 PM EDT

Article ID: 712388

Early-stage compounds show promise in a lab model of advanced prostate cancer

Michigan Medicine - University of Michigan

In mouse models and prostate cancer cell lines, researchers at the University of Michigan have demonstrated the preliminary effectiveness of a new set of compounds that offer a potential advance in the treatment of metastatic castration-resistant prostate cancer — one that appears to avoid many of the usual mechanisms of treatment resistance.

7-May-2019 6:30 AM EDT
  • Embargo expired:
    6-May-2019 11:00 AM EDT

Article ID: 712329

Men Taking Medications for Enlarged Prostate Face Delays in Prostate Cancer Diagnosis

University of California San Diego Health

University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.

2-May-2019 4:45 PM EDT

Showing results

110 of 683

Chat now!